191.033 articles found

Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction.

Zhi L, Qin Q, Muqeem T, Seifert EL, Liu W, Zheng S, Li C, Zhang H.

Neurobiol Aging · 2018-11-02

DOI: 10.1016/j.neurobiolaging.2018.10.025PMID: 30504091

Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.

Milosevic L, Gramer R, Kim TH, Algarni M, Fasano A, Kalia SK, Hodaie M, Lozano AM, Popovic MR, Hutchison WD.

Neurobiol Dis · 2018-11-02

DOI: 10.1016/j.nbd.2018.10.020PMID: 30391540

Altered regulation of serum lysosomal acid hydrolase activities in Parkinson's disease: A potential peripheral biomarker?

Niimi Y, Ito S, Mizutani Y, Murate K, Shima S, Ueda A, Satake W, Hattori N, Toda T, Mutoh T.

Parkinsonism Relat Disord · 2018-11-02

DOI: 10.1016/j.parkreldis.2018.10.032PMID: 30415794

COMPARATIVE BIOLOGICAL ANALYSIS OF DEMENTIA RISK FACTOR GENES FOR HUMANS AND CAENORHABDITIS ELEGANS

Murakami S.

Innovation in aging · 2018-11-01

TARGETING CANNABINOID TYPE 2 RECEPTORS TO MODULATE INFLAMMATION AND PROTECT AGAINST ASYN-INDUCED PD-LIKE PATHOLOGIES

Tansey M.

Innovation in aging · 2018-11-01

“IT’S A DISEASE OF FAMILIES”: NEUROLOGISTS’ INSIGHTS ON HOW PARKINSON’S DISEASE AFFECTS FAMILY DYNAMICS

Schwartz R, Zulman D, Gray C, Trivedi R.

Innovation in aging · 2018-11-01

CELLULAR SENESCENCE: A NOVEL CONTRIBUTOR TO BRAIN AGING AND NEURODEGENERATIVE DISEASE

Andersen J.

Innovation in aging · 2018-11-01

NEURODEGENERATION

Andersen J.

Innovation in aging · 2018-11-01

REACTIVE OXYGEN SPECIES, NRF2 SIGNALING, AND HUMAN AGING AND DISEASES

Zhang D.

Innovation in aging · 2018-11-01

NEUROLOGIST STRATEGIES FOR OPTIMIZING THE PARKINSON’S DISEASE CLINICAL ENCOUNTER

Schwartz R, Trivedi R, Lorenz K, Zulman D.

Innovation in aging · 2018-11-01

USING PROTEOMICS TO ELUCIDATE HOW VOLUNTARY EXERCISE COMBATS AGING PHENOTYPES IN MTDNA MUTATOR MICE

Ross J, Coppotelli G, Branca R, Lehtiö J, Sinclair D, Olson L.

Innovation in aging · 2018-11-01

UNCOVERING A NOVEL PATHWAY FOR NEURONAL AUTOPHAGY: A NEW THERAPEUTIC TARGET FOR ALZHEIMER’S AND PARKINSON’S DISEASE?

Andersen J.

Innovation in aging · 2018-11-01